2. The costs of appeal shall be borne by the Plaintiff.

Purport of claim and appeal

The first instance court.

A. On March 31, 2009, the Plaintiff entered into an insurance contract with the Defendant listed in the separate sheet (hereinafter “instant insurance contract”).

B. At the time, the Defendant subscribed to a special agreement on cancer diagnosis costs (the purchase amount of KRW 10 million; hereinafter “instant special agreement”) and its main contents are as follows.

1. Damage guaranteed (1) If the insured stated in a certificate of insurance coverage becomes final and conclusive after the date of commencement of coverage during the cover period of this Special Terms and Conditions, the company shall pay the following amounts in accordance with this Special Terms and Conditions:

25% of the purchase price of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of the purchase of

2. The definitions and diagnosis determination of cancer, other skin cancer and Athram cancer. ① In this Special Terms and Conditions, cancer means the disease specified in the Table 7 (See Attached Table 7; hereinafter the same shall apply) of malicious life classification table.

Provided, That this shall not include all cancer and C44 and C73 diseases.

3. In this special terms and conditions, the term "Athythram" refers to a disease falling under the classification number C73 of the malicious life classification table among the malicious life classification table.

(4) The diagnosis and confirmation of “Canceance,” “other skin cancer,” and “Athyrance cancer” shall be conducted by a person with a professional doctor’s license of an autopsy pathology or clinical pathology, and the diagnosis shall be based on organizational inspection, sacrine resistant examination, or opinion of absence regarding blood examination.

However, if it is not possible to conduct the above-mentioned pathological diagnosis, the clinical diagnosis of the above-mentioned celebite, “other skin cancer,” and “Aceleum cancer,” is of “Acele”, “other skin cancer,” and “Aceleum cancer.”